Understanding COVID-19 Pneumonia in PregnancyA Retrospective Study on Maternal and Neonatal Outcomes

Introduction:
COVID-19 has affected various populations worldwide, but pregnant women face unique challenges. This study explores the maternal and neonatal outcomes of COVID-19 pneumonia in pregnant patients, highlighting risk factors and treatment outcomes. The findings provide crucial insights into managing COVID-19 during pregnancy. Visit https://www.obstetricgynecoljournal.com for more groundbreaking research in this field.

Study Overview

• Objective: To identify risk factors associated with severe outcomes in pregnant women with COVID-19 pneumonia.
• Methods: A retrospective study involving 45 pregnant patients confirmed with COVID-19 pneumonia, using RT-PCR testing. The study covered data from the gynecology and obstetrics department over 2.5 years.

Key Findings:

• Demographics: 75% of cases were in the 20-35 age range, and 57% of patients had no comorbidities.
• Symptoms: 88.8% of patients showed symptoms at diagnosis, with fever (55.5%), fatigue (48.6%), and headache (35.5%) being the most common.
• ICU Admission: 30% of patients required ICU care, and 60% needed oxygen supplementation.
• Neonatal Outcomes: 80% of pregnancies resulted in live births, though there were cases of fetal death (13.3%) and low birth weight (26%).

Treatment and Management:

• Antibiotics: Azithromycin was the most commonly used antibiotic (65%), with others like amoxicillin and ceftriaxone administered based on bacterial infections.
• Anticoagulation: 51.2% of patients received preventive anticoagulation therapy due to the increased risk of thrombosis.

Discussion:
Pregnant women are more vulnerable to severe COVID-19 due to physiological changes that make them more prone to respiratory issues. This study’s findings emphasize the importance of early detection and careful management of pregnant women with COVID-19 to prevent complications such as severe respiratory distress and fetal distress.

Conclusion:
Pregnancy is a recognized risk factor for severe COVID-19, especially in women with comorbidities such as obesity and diabetes. Preventive measures and close monitoring are essential to improve maternal and neonatal outcomes.

Call-to-Action
Explore more studies at https://www.https://doi.org/10.29328/journal.cjog.1001163 and join the conversation by sharing your thoughts in the comments below!

Disclaimer: This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reusing of this material will not be handled by the author of this article.